Literature DB >> 11253960

Transcription factors and muscle cachexia: is there a therapeutic target?

W E Mitch1, S R Price.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11253960     DOI： 10.1016/S0140-6736(00)04177-5

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

1.  Malnutrition: a frequent misdiagnosis for hemodialysis patients.

Authors:  William E Mitch
Journal:  J Clin Invest       Date:  2002-08       Impact factor: 14.808

Review 2.  Genes, environment and sport performance: why the nature-nurture dualism is no longer relevant.

Authors:  Keith Davids; Joseph Baker
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

3.  Nutritional interventions for cancer-induced cachexia.

Authors:  Norleena P Gullett; Vera C Mazurak; Gautam Hebbar; Thomas R Ziegler
Journal:  Curr Probl Cancer       Date:  2011 Mar-Apr       Impact factor: 3.187

4.  A novel ubiquitin-binding protein ZNF216 functioning in muscle atrophy.

Authors:  Akinori Hishiya; Shun-ichiro Iemura; Tohru Natsume; Shinichi Takayama; Kyoji Ikeda; Ken Watanabe
Journal:  EMBO J       Date:  2006-01-19       Impact factor: 11.598

Review 5.  Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass.

Authors:  Marco Cassano; Mattia Quattrocelli; Stefania Crippa; Ilaria Perini; Flavio Ronzoni; Maurilio Sampaolesi
Journal:  J Muscle Res Cell Motil       Date:  2010-03-02       Impact factor: 2.698

6.  Identification of microRNAs involved in dexamethasone-induced muscle atrophy.

Authors:  He Shen; Teng Liu; Liangliang Fu; Shuhong Zhao; Bin Fan; Jianhua Cao; Xinyun Li
Journal:  Mol Cell Biochem       Date:  2013-05-29       Impact factor: 3.396

7.  Disruption of either the Nfkb1 or the Bcl3 gene inhibits skeletal muscle atrophy.

Authors:  R Bridge Hunter; Susan C Kandarian
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

8.  Sarcopenia and cachexia: the adaptations of negative regulators of skeletal muscle mass.

Authors:  Kunihiro Sakuma; Akihiko Yamaguchi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2012-01-12       Impact factor: 12.910

Review 9.  Cancer cachexia: traditional therapies and novel molecular mechanism-based approaches to treatment.

Authors:  Nagi B Kumar; Aslam Kazi; Tiffany Smith; Theresa Crocker; Daohai Yu; Richard R Reich; Kiran Reddy; Sally Hastings; Martine Exterman; Lodovico Balducci; Kyle Dalton; Gerold Bepler
Journal:  Curr Treat Options Oncol       Date:  2010-12

10.  Increased expression of the ubiquitin-proteasome pathway in murine myotubes by proteolysis-inducing factor (PIF) is associated with activation of the transcription factor NF-kappaB.

Authors:  A S Whitehouse; M J Tisdale
Journal:  Br J Cancer       Date:  2003-09-15       Impact factor: 7.640
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.